17
Li H﹟, Ren L﹟, Zhang L﹟, Wang Y﹟, Guo L﹟, Wang C, Xiao Y, Wang Y, Rao J, Wang X, Liu Y, Huang C, Gu X, Fan G, Li H, Lu B, Cao B*, Wang J*. High Anal Swab Viral Load Predisposes Adverse Clinical Outcomes in Severe COVID-19 Patients. Emerg Microbes Infect. 2020 Dec 1:1-26. doi: 10.1080/22221751.2020.1858700. Epub ahead of print.
18
Chen S﹟, Prettner K﹟, Cao B, Geldsetzer P, Kuhn M, Bloom DE, Bärnighausen T, Wang C*. Revisiting the association between temperature and COVID-19 transmissibility across 117 countries. ERJ Open Res. 2020 Nov 2;6(4):00550-2020. doi: 10.1183/23120541.00550-2020.
19
Shang L﹟, Xu J, Cao B*. Viral pneumonia in China: from surveillance to response. Lancet Public Health. 2020 Dec;5(12):e633-e634. doi: 10.1016/S2468-2667(20)30264-4.
20
Yahav D﹟*, Yelin D﹟, Eckerle I, Eberhardt CS, Wang J, Cao B, Kaiser L. Definitions for COVID-19 reinfection, relapse and PCR re-positivity. Clin Microbiol Infect. 2020 Dec 4:S1198-743X(20)30724-2. doi: 10.1016/j.cmi.2020.11.028. Epub ahead of print.
21
Shuai Liu#, Hui Li, Yeming Wang, Haibo Li, Sisi Du, Xiaohui Zou, Xulong Zhang, Bin Cao*.High Expression of IL-36g in Influenza Patients Regulates Interferon Signaling Pathway and Causes Programmed Cell Death During Influenza Virus Infection. Frontiers in Immunology. 22 October 2020.doi: 10.3389/fimmu.2020.552606
22
Zhibo Liu#, Xia Li#, Guohui Fan#, Fei Zhou, Yeming Wang, Lixue Huang, Jiapei Yu, Luning Yang, Lianhan Shang, Ke Xie, Jiuyang Xu, Zhisheng Huang, Xiaoying Gu, Hui Li, Yi Zhang, Yimin Wang, Zhenghui Huang*, Bin Cao*. Low-to-moderate dose corticosteroids treatment in hospitalized adults with COVID-19 .Clin Microbiol Infect.2020 Sep 9;S1198-743X(20)30599-1.doi: 10.1016/j.cmi.2020.09.045.
23
Lili Ren L#, Guohui Fan#, Wenjuan Wu#, Li Guo#, Yeming Wang#, Xia Li#, Conghui Wang, Xiaoying Gu, Caihong, Ying Wang, Geng Wang, Fei Zhou, Zhibo Liu, Qing Ge, Yi Zhang, Hui Li, Lulu Zhang, Jiuyang Xu, Chen Wang, Jianwei Wang*, Bin Cao*. Antibody Responses and Clinical Outcomes in Adults Hospitalized with Severe COVID-19: A Post hoc Analysis of LOTUS China Trial. Clin Infect Dis. 2020 Aug 25;ciaa1247. doi: 10.1093/cid/ciaa1247.
24
Fan G#, Tu C# , Zhou F#, Liu Z#, Wang Y#, Song B , Gu X, Wang Y , Wei Y, Li H, Wu X , Xu J, Tu S , Zhang Y, Wu W* , Cao B*.Comparison of severity scores for COVID-19 patients with pneumonia: a retrospective study. Eur Respir J. 2020 Jul 16;2002113. doi: 10.1183/13993003.02113-2020.
25
Liu Z# , Li Y# , Tian X# , Liu Q#, Li E#, Gu X#, Liu M#, Xu J, He Z, Huang Y, Xu S, Lai G, Chen Y, Zhang X, Zhang T, Xu J, Zhu L, Qu J*, Cao B*. Airway-invasion-associated pulmonary computed tomography presentations characteristic of invasive pulmonary Aspergillosis in non-immunocompromised adults: a National Multicenter Retrospective Survey in China. Respir Res. 2020 Jul 7;21(1):173.doi: 10.1186/s12931-020-01424-x.
26
Yin H#, Wang S# , Qu J , Zhou F , Wang C* , Cao B* , For CAP-China. Long-term prognosis of adolescent and middle-aged Chinese patients with low-medium risk community-acquired pneumonia: a cohort study. Clin Respir J. 2020 May 31. doi: 10.1111/crj.13224.
27
Zhang Y#, Wang Y, Zhao J, Xiong Z, Fan Y, Zhang W, Zou X, Wang C, Han J, Li B, Lu B, Cao B*, CAP-China Network. Severity and mortality of respiratory syncytial virus vs influenza A infection in hospitalized adults in China. Influenza Other Respir Viruses. 2020 May 25.doi: 10.1111/irv.12754.
28
Gu X#, Zhou F, Wang Y, Fan G, Cao B*. Respiratory viral sepsis: epidemiology, pathophysiology, diagnosis and treatment. Eur Respir Rev. 2020 Jul 21;29(157):200038. doi: 10.1183/16000617.0038-2020. Print 2020 Sep 30.
29
Sun L#, Chen W#, Li H# , Li L#, Zou X , Zhao J, Lu B , Li B, Wang C , Li H , Liu Y, Cao B*. Phenotypic and genotypic analysis of KPC-51 and KPC-52, two novel KPC-2 variants conferring resistance to ceftazidime/avibactam in the KPC-producing Klebsiella pneumoniae ST11 clone background. J Antimicrob Chemother. 2020 Jul 28;dkaa241. doi: 10.1093/jac/dkaa241.
30
Xu J#, Huang C#, Fan G#, Liu Z#, Shang L, Zhou F, Wang Y, Yu J, Yang L, Xie K, Huang Z, Huang L, Gu X, Li H, Zhang Y, Wang Y, Hayden F G, Horby P W, Cao B*, Wang C*. Use of angiotensin converting enzyme inhibitors and angiotensin II receptor blockers in context of COVID-19 outbreak: a retrospective analysis. Front. Med., [online ahead of print] doi: 10.1007/s11684-020-0800-y
31
Jiuyang Xu#,Jiapei Yu,Luning Yang,Fei Zhou,Hui Li,Bin Cao*.Influenza Virus in Community-Acquired Pneumonia:Current Understanding and Knowledge Gaps.Semin Respir Crit Care Med 2020;00:1–13.DOI:https://doi.org/10.1055/s-0040-1710584.
32
Yeming Wang#, Dingyu Zhang#, Guanhua Du#, Ronghui Du#, Jianping Zhao#, Yang Jin#, Shouzhi Fu#, Ling Gao#, Zhenshun Cheng#, Qiaofa Lu#,Yi Hu#, Guangwei Luo#,Bin Cao*, Chen Wang*.Remdesivir in adults with severe COVID-19: a randomised,double-blind, placebo-controlled, multicentre trial.The Lancet,Published Online April 29, 2020,DOI:https://doi.org/10.1016/S0140-6736(20)31022-9
